SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 163 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,960,920 | -31.9% | 2,821,000 | -1.8% | 1.65% | -21.4% |
| Q2 2023 | $60,110,960 | -26.4% | 2,872,000 | -25.7% | 2.10% | -22.5% |
| Q1 2023 | $81,635,136 | -45.3% | 3,865,300 | -34.1% | 2.71% | -16.1% |
| Q4 2022 | $149,162,450 | +11.1% | 5,861,000 | +4.9% | 3.23% | +18.4% |
| Q3 2022 | $134,253,000 | +28.0% | 5,586,900 | +2.5% | 2.73% | +13.4% |
| Q2 2022 | $104,858,000 | +25.1% | 5,450,000 | +13.0% | 2.41% | +37.9% |
| Q1 2022 | $83,831,000 | -20.6% | 4,823,400 | 0.0% | 1.75% | -22.0% |
| Q4 2021 | $105,584,000 | +14.5% | 4,823,400 | 0.0% | 2.24% | +9.6% |
| Q3 2021 | $92,175,000 | +16.3% | 4,823,400 | +4.5% | 2.04% | -4.7% |
| Q2 2021 | $79,240,000 | -7.9% | 4,615,000 | +20.0% | 2.14% | -9.8% |
| Q1 2021 | $85,997,000 | +16.9% | 3,846,000 | +16.3% | 2.38% | -0.5% |
| Q4 2020 | $73,570,000 | +168.8% | 3,308,000 | +78.4% | 2.39% | +88.2% |
| Q3 2020 | $27,367,000 | +20.9% | 1,854,100 | +21.4% | 1.27% | -12.5% |
| Q2 2020 | $22,636,000 | – | 1,527,400 | – | 1.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |